US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing

      The recalled hoses can burst, posing an impact hazard and a risk of temporarily impaired hearing. … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets

Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets

June 13, 2017 By The FDA Leave a Comment

(PRINCETON, N.J. – June 10, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets.

Patients should not stop taking Eliquis without consulting with their physician. Patients who are prescribed Eliquis 5 mg for an irregular heartbeat (atrial fibrillation) and take an Eliquis 2.5 mg tablet instead, particularly for a prolonged period, would have an increased probability of stroke, a moving blood clot, or death. For patients with Deep Vein Thrombosis (DVT), a blood clot in one of the deep veins usually in the leg, and Pulmonary Embolism (PE), a blood clot in the lung, underdosing of the drug could lead to an increased risk of a growing or moving blood clot. Should that occur, it could be life-threatening or reversible depending on the severity and location of the blood clot. To date, there have not been any reports of injuries or illnesses related to this issue.

Eliquis tablets are indicated to reduce the risk of stroke and blood clots in people who have atrial fibrillation; it also treats blood clots in the veins of your legs or lungs as well as reduces the risk of forming a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery. Eliquis 5 mg tablets are packaged in 60-count bottles, lot HN0063, Exp 09/2019, NDC 0003-0894-21. The recalled lot was distributed Nationwide in the U.S. to wholesalers and retail pharmacies in February 2017.

There are distinct visible differences between the two tablet strengths including colors, size and markings that distinguish the 2.5 mg and 5 mg tablets (see photos) and decrease the likelihood of an incorrect dose. The 2.5 mg presentation is a yellow, round, biconvex, film-coated tablet with “893” debossed on one side and “2½” on the other side. The 5 mg presentation is a pink, oval, biconvex, film-coated tablet with “894” debossed on one side and “5” on the other side.

Patient safety is our first priority. Bristol-Myers Squibb has notified wholesalers and pharmacies to arrange for return and replacement of any recalled product. Consumers that have product being recalled (Lot #HN0063) should contact their physician and call the Bristol-Myers Squibb Customer Information Center at 1-800-332-2056, Monday – Friday, from 8 AM – 8 PM EST or visit BMS.com for more information. Please see Eliquis U.S. Full Prescribing Information, including Boxed Warnings .

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking this drug product.

Complete and submit the report Online: www.fda.gov/medwatch/report.htm. Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

###

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing

July 23, 2025 By The CPSC

Curtis International Recalls Frigidaire-brand Minifridges Due to Fire and Burn Hazards; More Than $700,000 Reported in Property Damage

July 23, 2025 By The CPSC

Pura Scents Recalls Detachable Covers of Smart Home Fragrance Diffusers Due to Magnet Ingestion Hazard

July 23, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

LED Gloves Recalled Due to Risk of Serious Injury or Death from Battery Ingestion; Violates the Mandatory Toy Standard and Child Resistant Coin Battery Packaging Standard; Sold on Amazon by Minongad

July 23, 2025 By The CPSC

Diamond G Forest Products Recalls Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

Innovative Designs Recalls Minecraft Light-Up Slap Ruler Bracelets Due to Risk of Serious Injury or Death from Button Cell Battery Ingestion Hazard; Violates Mandatory Standard for Toys

July 23, 2025 By The CPSC

Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

FENGQS Electric Bikes Recalled Due to Fire and Burn Hazards; Risk of Serious Injury or Death; Sold on Amazon

July 23, 2025 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging

July 23, 2025 By The CPSC

FENGQS Electric Bikes Recalled Due to Fire and Burn Hazards; Risk of Serious Injury or Death; Sold on Amazon

July 23, 2025 By The CPSC

Aiho Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment; Violates Mandatory Standard; Sold on Walmart.com by Aiho

July 23, 2025 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Winston Products Recalls 5/8-Inch HydroTech Expandable Burst-Proof Hoses Due to Risk of Impact Hazard and Temporarily Impaired Hearing
  • Curtis International Recalls Frigidaire-brand Minifridges Due to Fire and Burn Hazards; More Than $700,000 Reported in Property Damage
  • Pura Scents Recalls Detachable Covers of Smart Home Fragrance Diffusers Due to Magnet Ingestion Hazard
  • iMirror Inc. Recalls Electric Bug Zapper Racket, Fly Swatter, and Mosquito Swatter Due to Shock Hazard
  • Transpro US Recalls Electric Scooters with Unauthorized Lithium-Ion Battery UL Certification Labels Due to Fire and Burn Hazards; Risk of Serious Injury and Death; $200,000 in Property Damage Reported
  • LED Gloves Recalled Due to Risk of Serious Injury or Death from Battery Ingestion; Violates the Mandatory Toy Standard and Child Resistant Coin Battery Packaging Standard; Sold on Amazon by Minongad
  • Diamond G Forest Products Recalls Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging
  • Innovative Designs Recalls Minecraft Light-Up Slap Ruler Bracelets Due to Risk of Serious Injury or Death from Button Cell Battery Ingestion Hazard; Violates Mandatory Standard for Toys
  • Creekwood Naturals Recalls 100% Natural Pure Gum Spirits of Turpentine Bottles Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child Resistant Packaging
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in